Skip to main
MDGL
MDGL logo

Madrigal Pharmaceuticals (MDGL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Madrigal Pharmaceuticals (MDGL) Stock

About Madrigal Pharmaceuticals (MDGL)

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on Ma...read more
Market cap$6.72B
Yesterday's volume20
Revenue (TTM)$317.38M
Avg. daily volume344.03K
EBITDA (TTM)-$423.84M
Open$303.09
Price / earnings ratio-16.77x
Yesterday's range$299.21 - $308.92
Debt / equity16.85x
52 week range$200.63 - $377.46
5 year debt / equity13.97x
Beta (LTM)0.9x
Interest coverage-33.94x
Dividend & yield$0.00 (0.00%)
Current ratio5.91x
Ex-dividend date
Next earningsAug 6, 2025
Dividend payable date

Madrigal Pharmaceuticals Stock Rating

What analysts recommend for MDGL stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 53%
Buy 35%
Hold 6%
Sell 6%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for MDGL stock is $6.72B

The current P/E ratio for MDGL stock is -16.77

The 52-week high for MDGL stock is $377.46. The current MDGL stock price $undefined is 100.00% below its 52-week high

The 52-week low for MDGL stock is $200.63. The current MDGL stock price $undefined has increased 100.00% from its 52-week low

No, the MDGL stock does not pay dividends to its shareholders

The target price for MDGL stock is $321.82 based on the average of what a group of analyst think MDGL stock could be worth at a future date. This is not a prediction by Public.com

How to buy MDGL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MDGL stock

    Navigate to the Explore page. Then, type MDGL into the search bar. When you see MDGL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MDGL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Madrigal Pharmaceuticals Stock Earnings

The value each MDGL share was expected to gain vs. the value that each MDGL share actually gained.

Madrigal Pharmaceuticals (MDGL) reported Q1 2025 earnings per share (EPS) of -$3.32, beating estimates of -$3.79 by 12.40%. In the same quarter last year, Madrigal Pharmaceuticals's earnings per share (EPS) was -$7.38. Madrigal Pharmaceuticals is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of -$3.65.

Buy Madrigal Pharmaceuticals (MDGL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.